3 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow B-cell Mediated Autoimmune Disorders: new trials by email Literature Review of B-cell Mediated Autoimmune Disorders trials Research Report on B-cell Mediated Autoimmune Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel No Intervention - B-cell Mediated Autoimmune Disorders | Recruiting | TG Therapeutics, Inc. | 32 | 2027-05-01 | 2026-10-29 | |
| Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease Anti-BCMA-CD19 CAR-T cells - IgG4 Related Disease, B-cell Mediated Autoimmune Disorders | Phase 2 | Recruiting | Chinese PLA General Hospital | 9 | 2025-09-05 | 2025-09-03 |
| A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders Azercabtagene zapreleucel (azer-cel) - B-cell Mediated Autoimmune Disorders | Phase 1 | Recruiting | TG Therapeutics, Inc. | 100 | 2025-05-06 | 2026-10-27 |
Immunoglobulin G4-Related Disease (1) · Multiple Sclerosis (1) · Myasthenia Gravis (1) · Neuromyelitis Optica (1) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
Autoimmune Diseases (2) · Immune System Diseases (2) · Autoimmune Diseases of the Nervous System (1) · Chronic Disease (1) · Cranial Nerve Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Eye Diseases (1) · Myelitis, Transverse (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurodegenerative Diseases (1)
TG Therapeutics, Inc. (2) · Chinese PLA General Hospital (1)
United States (2) · China (1)